Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05033041 · ClinicalTrials.gov registry record · Phase 4
Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
NCT05033041 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 72 participants.
The verdict
NCT05033041, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
Study Summary
Our objective is to compare gastric volumes (mL) between women who receive metoclopramide versus placebo prior to scheduled cesarean delivery in appropriately fasted patients. If metoclopramide is found not to reduce gastric volumes this would inform future practice guidelines for obstetric anesthesia, which currently recommends metoclopramide administration prior to cesarean deliveries. We hypothesize that metoclopramide given to women with appropriate fasting prior to cesarean delivery does not result in any clinically significant reduction in gastric volume (mL) and therefore does not provide any additional benefit for aspiration prophylaxis but may expose patients to unnecessary side effects. A secondary objective will be to evaluate if gastric volume is a significant predictor of intraoperative nausea and vomiting.
Interventions
- DRUG Study drug metoclopramide
- DRUG Study drug placebo administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-10-20 |
| Est. Completion | 2024-02-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05033041
The ClinicalTrials.gov registry entry for NCT05033041 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Study drug metoclopramide is the first listed.
NCT05033041 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05033041 about?
NCT05033041 is a clinical study titled "Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide". Our objective is to compare gastric volumes (mL) between women who receive metoclopramide versus placebo prior to scheduled cesarean delivery in appropriately fasted patients. If metoclopramide is found not to reduce gastric volumes this would inform future practice guidelines for obstetric anesthes...
What is the current status of trial NCT05033041?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2021-10-20. Estimated completion is 2024-02-08.
What interventions are being tested in trial NCT05033041?
The interventions under investigation include: Study drug metoclopramide (DRUG), Study drug placebo administration (DRUG).
Who is sponsoring clinical trial NCT05033041?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.